US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Sept. 29 for "Lassa virus-specific nanobodies and methods of their use" (Maryland, Connecticut, Massachusetts, District Of Columbia Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,284, issued on Sept. 29, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Lassa virus-specific nanobodies and methods of their use" was invented by Mitchell Ho (Urbana, Md.), Peter D. Kwong (Washington), Zhijian Duan (Columbia, Md.), Yaping Sun (New Haven, Conn.), Sao-Fong Cheung (Rockville, Md.) and Jason J. Gorman (Lakeville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Single-domain monoclonal antibodies that specifically bind Lassa virus glycoprotein (GPC) are described. The single-domain antibodies ("nanobodies") were isolated from camel (VHH) and s...